Marta Chełmińska

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

William W. Busse, Eugene R. Bleecker, J Mark FitzGerald et al. · The Lancet Respiratory Medicine · 2018 · 298 citations

Asthma, Rheumatology, Extension Trial +10

Association between sensitization to Aureobasidium pullulans (Pullularia sp) and severity of asthma

Marek Niedoszytko, Marta Chełmińska, Ewa Jassem et al. · Annals of Allergy Asthma & Immunology · 2007 · 67 citations

Asthma, Allergy, Allergy Medicine +7

Patterns of motivations and ways of quitting smoking among Polish smokers: A questionnaire study

Alicja Siemińska, Krzysztof Buczkowski, Ewa Jassem et al. · BMC Public Health · 2008 · 61 citations · Full text

β‐blockers and ACE inhibitors are not a risk factor for severe systemic sting reactions and adverse events during venom immunotherapy

Gunter J. Sturm, Sereina A. Herzog, Werner Aberer et al. · Allergy · 2021 · 44 citations · Full text

Analysis of Safety, Risk Factors and Pretreatment Methods during Rush Hymenoptera Venom Immunotherapy

Lucyna Górska, Marta Chełmińska, Krzysztof Kuziemski et al. · International Archives of Allergy and Immunology · 2008 · 33 citations